GLI1 and pancreatic neoplasm: For example, α-mangostin inhibits hypoxia-driven ROS-induced aggression against pancreatic cancer cells by reducing ROS production, which leads to inhibition of HIF-1α stabilization, GLI1 expression, and EMT [13].